Here are my thoughts after watching Malou's interview with Björn Eklund and Bragée.
It felt a bit odd, like an advertisement for Björn Eklund's book, which he apparently has distributed to officials in the Swedish government's Social Committee.
But it is framed as something that will give ME patients hope -
because one person played Russian roulette with his life, and won.
When others in the same situation weren't so lucky and suffered severe deterioration and were left indebted. Or even died. None of this is mentioned in the show.
I wish the Rituximab situation would have been elaborated upon and described with more nuance.
They just mention they've talked about the study before, and the results were negative, eg. did not give any evidence to use the medicine as a treatment for ME patients.
Eklund describes how he decided to "up the ante" when he didn't feel any difference after the forth treatment. He increased the dosage from 2x500 to 5x1000 and says he started to feel better after the first dose of 1000.
Eklund says he traveled to Norway two more times for doses of 2x2000, and felt increasingly better.
He describes himself as 90% recovered now, but is taking antivirals prescribed by Jonas Axelsson from the RED Clinic.
I find it strange that a patient can decide the dosage of such a strong medicine themselves. It's also weird that 'Malou efter tio' chooses to highlight such a special and individual story and frame it as significant for the ME field at large.
That single individuals recover or improve considerably isn't new, whether spontaneously or in connection with a treatment.
The fact that the Norwegian doctor Dagfinn, who administered the medicine, had his license revoked was not mentioned either. That's undeniably interesting information.
There's a lot of spin, and things are omitted that would nuance the picture.
I don't know who's responsible, if it's Malou or if Bragée could have contributed to a more well rounded picture.
The editors of the show don't seem to do much research before the features on ME.
Bragée said it would be great if larger and more studies could be done on Rituximab, but the medicine is so expensive that no clinic can afford to do a study.
Is that really something that should be done?
More studies on Rituximab?
Isn't what we need to move on to be able to categorize different subgroups?
But they weren't able to distinguish any subgroups in the Rituximab study either, is that correct?
By the way, how did Fluge and Mellas' Cyclophosphamide study go?
I haven't read Björn Eklund's book, but single individuals with ME recovering and/or improving isn't new, so I really don't understand how this story creates hope?
That ME researchers applying for grants, from the NIH for example, get them approved, that would give me hope.
Or that the research grants for ME were on a par with grants for MS or Alzheimer's.
Or that knowledge of ME in health care systems, municipalities and Social Security Agencies was so great, and the disease so accepted, that we got the support and care we need without hesitation and while being treated with respect. That would give me hope.
Björn Eklund felt he could just as easily "throw in the towel", "had nothing to lose" when he had been bedridden 23 hours/day for 2 1/2 years. That doesn't mean all severe ME patients feel that way, and not the whole time.
More biomedical specialist clinics (like Stora Sköndal, which is closing down) would improve the situation a lot for people living with ME. Because it's not just about the disease itself, but also about being mistrusted and neglected by the healthcare system, society at large and sometimes even friends and family.
I would love to get better, but even if I don't, I want to live. I love my life, however restricted it might be, and personally I would never risk my life for a chance to get well. "
Edit: clarity, grammar